Paper2007779
Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients.
Naber AH and 2 others. J Hepatol, 1991. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. Papers, record 2007779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2007779
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension, Portal | Major topic |
| Liver Diseases | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Antineoplastic Agents | |
| Biopsy | |
| Female | |
| Humans | |
| Hyperplasia | |
| Immunosuppressive Agents | |
| Liver | |
| Male | |
| Middle Aged |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41256184 | Severe Bleeding From Portal Hypertension in a Young Patient With Common Variable Immunodeficiency-Associated Nodular Regenerative Hyperplasia. | ACG Case Rep J | 2025 | https://conductscience.org/library/papers/41256184 | PubMed |
| 39569693 | Nodular Regenerative Hyperplasia: Report of 82 Patients and Systematic Review of Literature. | United European Gastroenterol J | 2024 | https://conductscience.org/library/papers/39569693 | PubMed |
| 38536628 | Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH). | Hepatol Int | 2024 | https://conductscience.org/library/papers/38536628 | PubMed |
| 37565050 | Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation. | Transpl Int | 2023 | https://conductscience.org/library/papers/37565050 | PubMed |
| 36341360 | Liver disease accompanied by enteropathy in common variable immunodeficiency: Common pathophysiological mechanisms. | Front Immunol | 2022 | https://conductscience.org/library/papers/36341360 | PubMed |
| 31191844 | Portal vein thrombosis leading to pre-sinusoidal non-cirrhotic portal hypertension resulting in decreased synthetic function of the liver. | Gastroenterol Hepatol Bed Bench | 2019 | https://conductscience.org/library/papers/31191844 | PubMed |
| 30063483 | Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol-thiopurine cotherapy. | Eur J Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/30063483 | PubMed |
| 29512050 | Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease. | Clin Pharmacokinet | 2018 | https://conductscience.org/library/papers/29512050 | PubMed |
| 28815029 | Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units. | United European Gastroenterol J | 2017 | https://conductscience.org/library/papers/28815029 | PubMed |
| 26904707 | Splenic Marginal Zone Lymphoma in the Setting of Noncirrhotic Portal Hypertension. | J Investig Med High Impact Case Rep | 2015 | https://conductscience.org/library/papers/26904707 | PubMed |
| 26229397 | Benign liver tumors in pediatric patients - Review with emphasis on imaging features. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26229397 | PubMed |
| 25755321 | Noncirrhotic portal hypertension. | J Clin Exp Hepatol | 2011 | https://conductscience.org/library/papers/25755321 | PubMed |
| 22956964 | Noncirrhotic Portal Hypertension due to Nodular Regenerative Hyperplasia Treated with Surgical Portacaval Shunt. | Case Rep Med | 2012 | https://conductscience.org/library/papers/22956964 | PubMed |
| 21472097 | Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/21472097 | PubMed |
| 18647320 | Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. | Clin Exp Immunol | 2008 | https://conductscience.org/library/papers/18647320 | PubMed |
| 18439425 | Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. | Gastroenterology | 2008 | https://conductscience.org/library/papers/18439425 | PubMed |
| 17504943 | Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. | Gut | 2007 | https://conductscience.org/library/papers/17504943 | PubMed |
| 16533469 | Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy? | Curr Gastroenterol Rep | 2006 | https://conductscience.org/library/papers/16533469 | PubMed |
| 16510033 | Evaluation of nonmalignant liver masses. | Curr Gastroenterol Rep | 2006 | https://conductscience.org/library/papers/16510033 | PubMed |
| 9166561 | Pseudotumoral presentation of nodular regenerative hyperplasia of the liver: imaging in five patients including MR imaging. | Eur Radiol | 1997 | https://conductscience.org/library/papers/9166561 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2007779
GET https://conductscience.org/api/papers/v1/2007779/cited_by?page=2